Nicotinic Cholinergic Receptor Binding Sites in the Brain: Regulation in Vivo
The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Abstract
Tritiated acetylcholine was used to measure binding sites with characteristics of nicotinic cholinergic receptors in rat brain. Regulation of the binding sites in vivo was examined by administering two drugs that stimulate nicotinic receptors directly or indirectly. After 10 days of exposure to the cholinesterase inhibitor diisopropyl fluorophosphate, binding of tritiated acetylcholine in the cerebral cortex was decreased. However, after repeated administration of nicotine for 10 days, binding of tritiated acetylcholine in the cortex was increased. Saturation analysis of tritiated acetylcholine binding in the cortices of rats treated with diisopropyl fluorophosphate or nicotine indicated that the number of binding sites decreased and increased, respectively, while the affinity of the sites was unaltered.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“It has been shown that high-dose chronic and intermittent nicotine exposure increases levels of high-affinity nicotinic receptors in adult humans and rodents (10–14).”
In the citing paper
“Repeated or prolonged nicotine exposure increases the number of high-affinity (mainly α4β2*) nicotine-binding sites, in heterologous systems (41, 42), nicotine-treated animals (11, 12), and in post mortem brains of smokers (ref. 10; for review, see ref. 43).”
In the citing paper
“animals exposed to nicotine chronically exhibit increased levels of nAChRs in the brain (Marks et al., 1983(Marks et al., , 1985(Marks et al., , 1992;;Schwartz and Kellar, 1983)”
From Human Tobacco Smokers in Early Abstinence Have Higher Levels of β2* Nicotinic Acetylcholine Receptors than Nonsmokers (2006) · cites this paper as Schwartz and Kellar, 1983
In the citing paper
“A hallmark of chronic nicotine administration is the upregulation of nicotinic receptors in the brain (Marks et al, 1983; Schwartz and Kellar, 1983) and recent studies in humans have suggested a functional role of these receptors in relapse vulnerability (Cosgrove et al, 2009).”
From Divergent Functional Effects of Sazetidine-A and Varenicline During Nicotine Withdrawal (2013) · cites this paper as Schwartz and Kellar, 1983
In the citing paper
“Chronic nicotine administration increases ␣42 neuronal nicotinic acetylcholine receptor (nAChR) density in brain.”
From Chronic Sazetidine-A at Behaviorally Active Doses Does Not Increase Nicotinic Cholinergic Receptors in Rodent Brain (2012) · cites this paper as Schwartz and Kellar, 1983
7 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
A new and rapid colorimetric determination of acetylcholinesterase activity
Ellman, G. L., Courtney, K. D., Andres, V., & Featherstone, R. M. (1961) · Biochemical Pharmacology · doi:10.1016/0006-2952(61)90145-9 · Cited by 27,126
Muscarinic Cholinergic Binding in Rat Brain
Yamamura, H. I., & Snyder, S. H. (1974) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.71.5.1725 · Cited by 1,203
Annual Review of Pharmacology,
Williams, J. F. (1975) · Archives of Internal Medicine · doi:10.1001/archinte.1975.00330100136032 · Cited by 386
Stereospecific Nicotine Receptors on Rat Brain Membranes
Romano, C., & Goldstein, A. (1980) · Science · doi:10.1126/science.7433991 · Cited by 319
Receptor Adaptations to Centrally Acting Drugs
Creese, I., & Sibley, D. R. (1981) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pa.21.040181.002041 · Cited by 290
THESLEFF, S. (1955) · Acta Physiologica Scandinavica · doi:10.1111/j.1748-1716.1955.tb01242.x · Cited by 281
Nicotinic cholinergic receptors labeled by [3H]acetylcholine in rat brain.
Schwartz, R. D., McGee, R., & Kellar, K. J. (1982) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)15102-x · Cited by 261
Self-citationNicotine-induced antinociception in rats and mice: correlation with nicotine brain levels.
Tripathi, H. L., Martin, B. R., & Aceto, M. D. (1982) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)33022-3 · Cited by 171
The action potential of the superior cervical ganglion
Eccles, J. C. (1935) · The Journal of Physiology · doi:10.1113/jphysiol.1935.sp003313 · Cited by 165
Regulation of neocortical muscarinic receptors: effects of drug treatment and lesions
McKinney, M., & Coyle, J. (1982) · Journal of Neuroscience · doi:10.1523/jneurosci.02-01-00097.1982 · Cited by 156
Research works printed but not linked: 2
- DALE, H.H., J PHARMACOL EXP THER 6: 174 (1914).
- PORSIUS, A. J., ARZNEIMITTEL-FORSCHUNG-DRUG RESEARCH 28: 1628 (1978).
Cited by
Items 301–400 of 481
Gözen, O., Nesil, T., Kanıt, L., Koylu, E. O., & Pöğün, Ş. (2016) · The American Journal of Drug and Alcohol Abuse · doi:10.1080/00952990.2016.1198799 · Cited by 19
“Nicotine is a unique agonist as exposure to nicotine causes the upregulation of its receptors in mice (4,5), rats (6), and human smokers (7,8).”
BackgroundGovind, A. P., Vallejo, Y. F., Stolz, J. R., Yan, J.-Z., Swanson, G. T., & Green, W. N. (2017) · eLife · doi:10.7554/elife.25651 · Cited by 17
Mahmood, H. M., Aldhalaan, H., Alshammari, T. K., Alqasem, M., Alshammari, M. A., Albekairi, N. A., & AlSharari, S. D. (2020) · Autism Research · doi:10.1002/aur.2342 · Cited by 19
“…cause an increase in the density of neuronal nicotinic receptor subtypes and upregulates some nAChRs within the CNS [Marks, Burch, & Collins, 1983; Schwartz & Kellar, 1983; Schwartz & Kellar, 1985; Ksir, Hakan, Hall, & Kellar, 1985; Wonnacott, 1990; Pauly, Marks, Gross, & Collins, 1991; Pauly,…”
BackgroundDonny, E. C., Lanza, S. T., Balster, R. L., Collins, L. M., Caggiula, A. R., & Rowell, P. P. (2004) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2004.02.005 · Cited by 20
“As noted in the introduction, repeated administration of nicotine induces desensitization and upregulation of nicotinic receptors (Marks et al., 1983; Schwartz and Kellar, 1983; Ksir et al., 1985; Wonnacott, 1990; Rowell and Li, 1997; Fenster et al., 1999).”
BackgroundThe effect of nicotine and haloperidol co-treatment on nicotinic receptor levels in the rat brain
Lee, M. J., Breese, C. R., Strook, M. L., & Leonard, S. S. (2001) · Molecular Brain Research · doi:10.1016/s0169-328x(00)00274-6 · Cited by 17
Cinciripini, P. M. (1986) · Psychopharmacology · doi:10.1007/bf00174072 · Cited by 17
“A possible explanation for this effect may be found in recent animal work which suggests that the number and possibly the affinity of cortical nicotinic cholinergic binding sites may be influenced by the habitual pattern of drug administration ( Schwartz and Kellar 1983 ).”
BackgroundDonaldson, J., & Hill, S. J. (1986) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1986.tb10171.x · Cited by 17
Tolerance to Organophosphorus Cholinesterase Inhibitors
Hoskins, B., & Ho, I. K. (1992) · Elsevier eBooks · doi:10.1016/b978-0-08-091726-9.50019-7 · Cited by 17
Advances in smoking cessation pharmacotherapy: Non-nicotinic approaches in animal models
Smith, L. C., & George, O. (2020) · Neuropharmacology · doi:10.1016/j.neuropharm.2020.108225 · Cited by 19
“…to receptor changes in the central nervous system and muscular-skeletal system, which contribute to tolerance, negative reinforcing effects, and withdrawal upon cessation (Marks, Burch et al. 1983, Schwartz and Kellar 1983, Benwell, Balfour et al. 1988, Wonnacott 1990, Grieder, Besson et al. 2019).”
BackgroundLyvers, M., & Miyata, Y. (1993) · Psychophysiology · doi:10.1111/j.1469-8986.1993.tb03348.x · Cited by 16
Acute tolerance to the locomotor stimulant effects of nicotine in the rat
Hakan, R. L., & Ksir, C. J. (1991) · Psychopharmacology · doi:10.1007/bf02246040 · Cited by 16
Morphological and biochemical differentiation of the human medulloblastoma cell line TE671
Siegel, H. N., & Lukas, R. J. (1988) · Developmental Brain Research · doi:10.1016/0165-3806(88)90225-8 · Cited by 16
Free, R. B., & McKay, D. B. (2001) · Brain Research · doi:10.1016/s0006-8993(00)03204-2 · Cited by 17
Hussmann, G. P., Yasuda, R. P., Xiao, Y., Wolfe, B. B., & Kellar, K. J. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.289546 · Cited by 21
Self-citationMetaxas, A., Al‐Hasani, R., Farshim, P. P., Tubby, K. C., Berwick, A., Ledent, C. A., Hourani, S. M. O., Kitchen, I., & Bailey, A. (2013) · Neuropharmacology · doi:10.1016/j.neuropharm.2013.03.023 · Cited by 17
Tapia, M. A., Jin, X., Tucker, B. R., Thomas, L. N., Walker, N. B., Kim, V. J., Albertson, S. E., Damuka, N., Krizan, I. M., Edassery, S. L., et al. (2022) · Neuropharmacology · doi:10.1016/j.neuropharm.2022.109066 · Cited by 19
Abreu‐Villaça, Y., Correa‐Santos, M., Dutra-Tavares, A. C., Paes‐Branco, D., Nunes‐Freitas, A. L., Manhães, A. C., Filgueiras, C. C., & Ribeiro‐Carvalho, A. (2016) · International Journal of Developmental Neuroscience · doi:10.1016/j.ijdevneu.2016.06.002 · Cited by 15
“It must be pointed out, however, that previous studies indicated that both nicotine and tobacco smoke affect primarily nAChRs and HC-3 binding site concentrations (Marks et al., 1983; Schwartz and Kellar, 1983; Slotkin et al., 2002; Trauth et al., 1999; Zhu et al., 2000).”
Bağdaş, D., Meade, J. A., Alkhlaif, Y., Muldoon, P. P., Carroll, F. I., & Damaj, M. I. (2018) · European Journal of Pain · doi:10.1002/ejp.1231 · Cited by 16
“Differences in nAChR subtypes, expression levels or availability (Schwartz and Kellar, 1983; Picciotto et al., 2000) in brain regions and peripheral nerves involved in processing the pain stimuli (Garland, 2012) or pain aversion (Hayes and Northoff, 2012) could explain why CPA and stretching behaviour did not respond…”
BackgroundClarke, P. B. S. (1989) · Progress in brain research · doi:10.1016/s0079-6123(08)62465-6 · Cited by 16
Muelken, P., Schmidt, C. E., Shelley, D., Tally, L., & Harris, A. C. (2015) · PLoS ONE · doi:10.1371/journal.pone.0144553 · Cited by 15
Nicotine Psychopharmacology: Policy and Regulatory
Henningfield, J. E., & Zeller, M. (2009) · Handbook of experimental pharmacology · doi:10.1007/978-3-540-69248-5_18 · Cited by 15
“All of this work supported the FDA’s conclusions that the addictive actions of tobacco were caused in part by the effects of nicotine on the structure and function of the body ( Schwartz and Kellar 1983; Henningfield et al. 1987, 1996; London et al. 1988; Grunberg et al. 1988).”
ResultHohnadel, E. J., Hernandez, C. M., Gearhart, D. A., & Terry, A. V. (2005) · Neuroscience Letters · doi:10.1016/j.neulet.2005.03.011 · Cited by 15
Pharmacology of neuronal nicotinic acetylcholine receptors: Effect of acute and chronic nicotine
Kellar, K. J., Dávila‐García, M. I., & Xiao, Y. (1999) · Nicotine & Tobacco Research · doi:10.1080/14622299050011921 · Cited by 15
Self-citationAuta, J., Longone, P., Guidotti, A., & Costa, E. (1999) · Journal of Molecular Neuroscience · doi:10.1385/jmn:13:1-2:31 · Cited by 14
“Schwartz and Kellar (1983), and shortly thereafter Marks et al. (1983), independently reported the seminal observation that protracted daily administration of either nicotine or other selective agonists of high-affinity brain nicotinic receptors increases the expression density of high-affinity…”
BackgroundBullock, A. E., Barke, K. E., & Schneider, A. S. (1994) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1994.62051863.x · Cited by 14
Araujo, D. M., Lapchak, P. A., Collier, B., & Quirion, R. (1989) · Progress in brain research · doi:10.1016/s0079-6123(08)62494-2 · Cited by 14
Genetic matters: Thirty years of progress using mouse models in nicotinic research
Marks, M. J. (2013) · Biochemical Pharmacology · doi:10.1016/j.bcp.2013.05.021 · Cited by 13
“The increase in nAChR with high affinity for agonists was initially observed in rats [60] and mice [61].”
BackgroundLiu, Y., Richardson, J. R., Tran, T. P., Al‐Muhtasib, N., Xie, T., Yenugonda, V. M., Sexton, H. G., Rezvani, A. H., Levin, E. D., Sahibzada, N., et al. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm4000374 · Cited by 16
“The extract was concentrated under reduced pressure, and then residue was purified by column chromatography on silica gel using a gradient of hexane-ethyl acetate (6:1 to 3:1) as the eluent to give the product (13) 422 mg as light yellow oil, Yield: 80%.”
MethodSelf-citationLee, A. M., Arreola, A. C., Kimmey, B. A., & Schmidt, H. D. (2014) · Behavioural Brain Research · doi:10.1016/j.bbr.2014.08.016 · Cited by 14
“Similar to the effects of nicotine, chronic varenicline exposure is associated with up-regulation of neuronal α4β2 nAChRs, which is thought to promote nicotine craving and relapse during smoking abstinence [12-15].”
BackgroundRomano, E., Angelis, F. D., Ulbrich, L., Jaco, A. D., Fuso, A., & Laviola, G. (2013) · Psychopharmacology · doi:10.1007/s00213-013-3388-y · Cited by 16
Altered nicotine reward-associated behavior following α4 nAChR subunit deletion in ventral midbrain
Peng, C., Engle, S. E., Yan, Y., Weera, M. M., Berry, J. N., Arvin, M. C., Zhao, G., McIntosh, J. M., Chester, J. A., & Drenan, R. M. (2017) · PLoS ONE · doi:10.1371/journal.pone.0182142 · Cited by 14
Semenova, S., Jin, X., McClure‐Begley, T. D., Tadman, M. P., Marks, M. J., & Markou, A. (2018) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2018.06.002 · Cited by 13
“Studies in rodents showed an upregulation of high affinity nicotine binding sites after chronic noncontingent nicotine exposure via external or internal osmotic minipumps, repeated nicotine injections or intravenous infusions (Collins et al., 1990; Fasoli et al., 2016; Marks et al., 1983; Rowell and Li, 1997; Sanderso…”
BackgroundRenda, A., & Nashmi, R. (2012) · Journal of Visualized Experiments · doi:10.3791/3516 · Cited by 13
Sun, Y. P., Wang, H. H., He, Q., & Cho, C. H. (2007) · Digestion · doi:10.1159/000112643 · Cited by 14
“The expression of α7nAChR in colon tissue, however, has never been discussed. Chronic nicotine administration increases the number of acetycholine-binding sites in the brains of mice [”
BackgroundZhang, X., Paterson, D., James, R. P., Gong, Z., Liu, C., Rosecrans, J. A., & Nordberg, A. K. (2000) · Behavioural Brain Research · doi:10.1016/s0166-4328(00)00205-9 · Cited by 12
Piatt, K. P., Zwartjes, R. E., & Bristow, D. R. (1996) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1996.tb16051.x · Cited by 13
d-Tubocurarine causes neuronal death when injected directly into rat brain
Dasheiff, R. M. (1985) · Experimental Neurology · doi:10.1016/0014-4886(85)90274-2 · Cited by 12
Nicotine/mecamylamine combination treatment for smoking cessation
Rose, J. E., Westman, E. C., & Behm, F. M. (1996) · Drug Development Research · doi:10.1002/(sici)1098-2299(199607/08)38:3/4<243::aid-ddr13>3.0.co;2-# · Cited by 31
Di, X.-J., Yan, J., Zhao, Y., Chang, Y.-Z., & Zhao, B.-L. (2012) · Science China Life Sciences · doi:10.1007/s11427-012-4401-0 · Cited by 11
Zhang, H. J., Zammit, M. D., Kao, C.-M., Govind, A. P., Mitchell, S. J., Holderman, N., Bhuiyan, M. P. I., Freifelder, R. H., Kucharski, A., Zhuang, X., et al. (2022) · Journal of Neuroscience · doi:10.1523/jneurosci.2484-21.2022 · Cited by 12
More than Smoke and Patches: The Quest for Pharmacotherapies to Treat Tobacco Use Disorder
Moerke, M. J., McMahon, L. R., & Wilkerson, J. L. (2020) · Pharmacological Reviews · doi:10.1124/pr.119.018028 · Cited by 14
“…it has long been known that nicotine receptor binding is increased in the brains of animals after chronic exposure to nicotine (Marks et al., 1983; Schwartz and Kellar, 1983; Sanderson et al., 1993) as well as in human smokers compared with nonsmokers (Benwell et al., 1988; Breese et al., 1997;…”
BackgroundStitzel, J. A., Farnham, D. A., & Collins, A. C. (1996) · Neuroscience · doi:10.1016/0306-4522(95)00584-6 · Cited by 12
Maturational changes in neonatal rat motor system with early postnatal administration of nicotine
Frischer, R. E., King, J. A., Rose, K. J., & Strand, F. L. (1988) · International Journal of Developmental Neuroscience · doi:10.1016/0736-5748(88)90039-1 · Cited by 11
Smolen, A. (1987) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(87)90615-0 · Cited by 11
Translational Research in Nicotine Dependence
Turner, J. R., Gold, A. B., Schnoll, R. A., & Blendy, J. A. (2013) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a012153 · Cited by 11
“In contrast to other subtypes, the a4b2 nAChR subtype has been shown to readily up-regulate following chronic exposure to nicotine, as evidenced by findings in cell culture (Xiao and Kellar 2004), rodents (Schwartz and Kellar 1983; Marks et al. 1985), monkeys (Picciotto et al.”
BackgroundNicotinic Regulation of Sympathoadrenal Catecholamine Secretion: Cross-Tolerance to Stress
Loon, G. R. V., Kiritsy‐Roy, J. A., Brown, L. V., & Bobbitt, F. A. (1987) · Advances in behavioral biology · doi:10.1007/978-1-4613-1911-5_16 · Cited by 13
Linking the CHRNA5 SNP to drug abuse liability: From circuitry to cellular mechanisms
Brynildsen, J. K., & Blendy, J. A. (2021) · Neuropharmacology · doi:10.1016/j.neuropharm.2021.108480 · Cited by 12
“The upregulation observed following chronic exposure to nicotine (Govind et al., 2009; Schwartz and Kellar, 1983) appears to largely involve α4β2-type receptors (Flores et al.”
BackgroundThe nicotinic receptors in the nervous system
Gotti, C., Sher, E., Chini, B., Fornasari, D., Esparís-Ogando, A., & Clementi, F. (1988) · Pharmacological Research Communications · doi:10.1016/s0031-6989(88)80112-7 · Cited by 11
Central nicotine binding sites: A study of post-mortem stability
Benwell, M. E. M., & Balfour, D. J. (1985) · Neuropharmacology · doi:10.1016/0028-3908(85)90205-9 · Cited by 11
Mirza, N. R., Misra, A., & Bright, J. L. (2000) · European Journal of Pharmacology · doi:10.1016/s0014-2999(00)00658-0 · Cited by 13
Hillard, C. J., & Pounds, J. J. (1993) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1993.tb03202.x · Cited by 10
Nicotinic Cholinergic Receptor Recognition Sites in Brain
Kellar, K. J., Schwartz, R. D., & Martino, A. M. (1987) · Advances in behavioral biology · doi:10.1007/978-1-4613-1911-5_30 · Cited by 12
Self-citationKeady, J. V., Hessing, M. C., Songrady, J. C., McLaurin, K. A., & Turner, J. R. (2024) · Biology of Sex Differences · doi:10.1186/s13293-024-00656-6 · Cited by 10
“Radioligand binding to nAChRs confirmed receptor upregulation in the nicotine treated group ( F(2,31) = 8.188, P = 0.0014), a canonical sign of chronic nicotine exposure observed in both rodents and humans [78–80].”
BackgroundInfluentialIzquierdo, P. G., Charvet, C., Neveu, C., Green, A. C., Tattersall, J. E. H., Holden-Dye, L. M., & O'Connor, V. M. (2023) · PLoS ONE · doi:10.1371/journal.pone.0284786 · Cited by 13
Foll, B. L., Chefer, S. I., Kimes, A. S., Stein, E. A., Goldberg, S. R., & Mukhin, A. G. (2016) · Psychopharmacology · doi:10.1007/s00213-016-4250-9 · Cited by 9
“pared to control animals (Besson et al. 2007; Marks et al. 1983; Schwartz and Kellar 1983).”
Tuan, E. W., Horti, A. G., Olson, T. T., Gao, Y., Stockmeier, C. A., Al‐Muhtasib, N., Dalley, C. B., Lewin, A. E., Wolfe, B. B., Sahibzada, N., et al. (2015) · Molecular Pharmacology · doi:10.1124/mol.115.099978 · Cited by 13
Self-citationReceptor systems: Will mining the receptorome yield novel targets for pharmacotherapy?
Roth, B. L. (2005) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2005.06.013 · Cited by 10
Sulfhydryl Modification of Two Nicotinic Binding Sites in Mouse Brain
Stitzel, J. A., Campbell, S. M., Collins, A. C., & Marks, M. J. (1988) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1988.tb03000.x · Cited by 9
Neurotransmitter System Interactions Revealed by Drug-Induced Changes in Motivated Behavior
Montgomery, A. M. J., & Grottick, A. J. (1999) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(98)00200-7 · Cited by 10
Yang, X., & Buccafusco, J. J. (1994) · Drug Development Research · doi:10.1002/ddr.430310203 · Cited by 9
Effect of cold stress on cholinergic receptors in the rat adrenal gland
Miner, L. L., Baruchin, A., & Kaplan, B. B. (1989) · Neuroscience Letters · doi:10.1016/0304-3940(89)90187-0 · Cited by 10
Quantitative assessment of tolerance development to diisopropylfluorophosphate
Lim, D.-K., Fernando, J. C. R., Hoskins, B., & Ho, I. K. (1987) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(87)90119-5 · Cited by 9
Chapter 21 Differential brain and peripheral nicotinic regulation of sympathoadrenal secretion
Loon, G. R. V., Kiritsy‐Roy, J. A., Pierzchała, K., Dong, L., Bobbitt, F. A., Marson, L., & Brown, L. V. (1989) · Progress in brain research · doi:10.1016/s0079-6123(08)62481-4 · Cited by 9
Density of α4β2* nAChR on the surface of neurons is modulated by chronic antagonist exposure
Zambrano, C. A., Short, C. A., Salamander, R. M., Grady, S. R., & Marks, M. J. (2015) · Pharmacology Research & Perspectives · doi:10.1002/prp2.111 · Cited by 8
“…(termed upregulation) of the nicotinic acetylcholine receptors (nAChR) principally for the high-affinity a4b2* nAChR subtype (Marks et al. 1983; Schwartz and Kellar 1983; Whiteaker et al. 1998; Davila-Garcia et al. 1999; Fenster et al. 1999; Lomazzo et al. 2011; Zambrano et al. ª 2015 The…”
BackgroundMann, T., Zilles, K., Klawitter, F., Cremer, M., Hawlitschka, A., Palomero‐Gallagher, N., Schmitt, O., & Wree, A. (2018) · Frontiers in Neuroanatomy · doi:10.3389/fnana.2018.00065 · Cited by 9
Moretti, M., Fasoli, F., Gotti, C., & Marks, M. J. (2017) · British Journal of Pharmacology · doi:10.1111/bph.13896 · Cited by 9
“Exposure to nicotine or tobacco increases levels of α4β2*-nAChR expression in rodents chronically exposed to nicotine (Marks et al., 1983; Schwartz and Kellar, 1983; Flores et al., 1992; Marks et al., 2011), human tobacco users (Benwell et al., 1988; Breese et al., 1997; Perry et al., 1999; Staley…”
Chapter 12 Properties of putative nicotine receptors identified on cultured cortical neurons
Lippiello, P. M. (1989) · Progress in brain research · doi:10.1016/s0079-6123(08)62472-3 · Cited by 8
Lapner, K. N., Montpetit, C. J., & Perry, S. F. (2000) · Journal of Experimental Biology · doi:10.1242/jeb.203.10.1589 · Cited by 8
Effects of Prolonged Depolarization on the Nicotinic Acetylcholine Receptors of PC12 Cells
Delorme, E. M., & McGee, R. (1988) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1988.tb10601.x · Cited by 8
The Effects of Chronic Nicotine Administration on Brain Nicotinic Receptor Numbers
Collins, A. C., & Marks, M. J. (1987) · Advances in behavioral biology · doi:10.1007/978-1-4613-1911-5_28 · Cited by 8
Zambrano, C. A., Salamander, R. M., Collins, A. C., Grady, S. R., & Marks, M. J. (2012) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.112.192542 · Cited by 8
“Chronic nicotine treatment increases the number of nAChR binding sites in rodent and human brain (Marks et al., 1983, 2011; Schwartz and Kellar, 1983; Benwell et al., 1988; Pauly et al., 1991; Breese et al., 1997; Perry et al., 1999; Sparks and Pauly, 1999; Nguyen et al., 2003), as well as in cells expressing nAChRs (…”
BackgroundBencherif, M., Byrd, G. D., Caldwell, W. S., Hayes, J. R., & Lippiello, P. M. (1997) · CNS Drug Reviews · doi:10.1111/j.1527-3458.1997.tb00331.x · Cited by 8
Henningfield, J. E., Keenan, R. M., & Clarke, P. B. S. (1996) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-60963-3_8 · Cited by 10
Effects of Nicotine on Dopaminergic Neurotransmission
Rowell, P. P. (2001) · Frontiers in neuroscience · doi:10.1201/9781420038521.ch3 · Cited by 7
Neurotoxicology of nicotine and tobacco
Levin, E. D. (2022) · Advances in neurotoxicology · doi:10.1016/bs.ant.2022.06.003 · Cited by 10
Melroy-Greif, W. E., Simonson, M. A., Corley, R. P., Lutz, S. M., Hokanson, J. E., & Ehringer, M. A. (2016) · Nicotine & Tobacco Research · doi:10.1093/ntr/ntw200 · Cited by 7
Upregulation of Opioid Receptors
Unterwald, E. M., & Howells, R. (2009) · Humana Press eBooks · doi:10.1007/978-1-59745-197-0_2 · Cited by 7
Zhou, Y., Brašić, J. R., Musachio, J. L., Zukin, S. R., Kuwabara, H., Crabb, A. H., Endres, C. J., Hilton, A., Fan, H., & Wong, D. F. (2005) · IEEE Nuclear Science Symposium and Medical Imaging Conference (NSS/MIC) · doi:10.1109/nssmic.2001.1008584 · Cited by 8
Vadász, C., Saito, M., O’Brien, D., Zavadil, J., Morahan, G., Chakraborty, G., & Wang, R. (2007) · Neurochemical Research · doi:10.1007/s11064-006-9250-4 · Cited by 6
“It is well established that long-term exposure to nicotine results in the upregulation of nicotinic acetylcholine surface receptors as seen in chronically nicotine-treated animal models [52, 53].”
BackgroundAging, Smoking and Hemispheric EEG Asymmetry
Knott, V., & Harr, A. (1997) · Canadian Journal on Aging / La Revue canadienne du vieillissement · doi:10.1017/s0714980800011016 · Cited by 6
The Aging of Cholinergic Synapses: Ontogenesis of Cholinergic Receptors
Nordberg, A. K. (1986) · Advances in behavioral biology · doi:10.1007/978-1-4684-5194-8_15 · Cited by 6
Effects of soman on vascular contractility of rabbit arteries
Hu, C., Hung, C., & Robinson, C. P. (1988) · Journal of Toxicology and Environmental Health · doi:10.1080/15287398809531154 · Cited by 6
The Biobehavioral Effects of Nicotine: Interactions with Brain Neurochemical Systems
Rosecrans, J. A. (1991) · Springer eBooks · doi:10.1007/978-1-4613-9112-8_5 · Cited by 9
Translational Research in Nicotine Addiction
Fisher, M. L., Pauly, J. R., Froeliger, B., & Turner, J. R. (2020) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a039776 · Cited by 9
Epidemiology of Parkinson's Disease: The Rotterdam Study
de Rijk, M. (1997) · RePub (Erasmus University Rotterdam) · Cited by 12
Zambrano, C. A., Escobar, D., Ramos-Santiago, T., Bollinger, I., & Stitzel, J. A. (2018) · Biochemical Pharmacology · doi:10.1016/j.bcp.2018.11.008 · Cited by 6
Receptor Binding Techniques in Neurotoxicology
Costa, L. G., Marinovich, M., & Galli, C. L. (1988) · Springer eBooks · doi:10.1007/978-1-4613-0887-4_16 · Cited by 5
The Effects of Nicotine on Learning and Memory
Gould, T. J. (2014) · The Receptors · doi:10.1007/978-1-4939-1167-7_11 · Cited by 5
α4β2 nicotinic acetylcholine receptors intrinsically influence body weight in mice
Dezfuli, G., Olson, T. T., Martin, L. M., Keum, Y., Siegars, B., Desai, A., Uitz, M., Sahibzada, N., Gillis, R. A., & Kellar, K. J. (2019) · Neuropharmacology · doi:10.1016/j.neuropharm.2019.107921 · Cited by 5
Self-citationRasmussen, B. A., Perry, D. C., O’Neil, J. N., Manaye, K. F., & Tizabi, Y. (2008) · Neurotoxicity Research · doi:10.1007/bf03033499 · Cited by 5
“…of regionally selective up-regulation of high-and low-affinity nAChR binding by chronic nicotine is consistent with previous results from our labs as well as others (Schwartz and Kellar, 1983; Marks et al., 1983; Pauly et al., 1991; Nguyen et al., 2003; Levin et al., 2005b; Rasmussen et al., 2007).”
ResultCentral Nervous System Plasticity and Pathology Induced by Exposure to Organophosphate Pesticides
Overstreet, D. H., & Schiller, G. D. (1992) · Springer eBooks · doi:10.1007/978-1-4615-3330-6_11 · Cited by 5
Fernando, J. C. R., Hoskins, B., & Ho, I. K. (1985) · Life Sciences · doi:10.1016/0024-3205(85)90524-7 · Cited by 5
Accelerated neuromuscular development in the rat with prenatal exposure to nicotine
Rose, K. J., & Strand, F. L. (1990) · International Journal of Developmental Neuroscience · doi:10.1016/0736-5748(90)90049-8 · Cited by 5
Wang, H., & Liu, C.-G. (1991) · Birkhäuser Basel eBooks · doi:10.1007/978-3-0348-7457-1_37 · Cited by 5
Nicotinic-Muscarinic Interactions in Cognitive Function
Levin, E. D., & Russell, R. W. (1992) · Birkhäuser Boston eBooks · doi:10.1007/978-1-4615-9843-5_11 · Cited by 5
Florin, F., Bonneau, B., Briseño-Roa, L., Bessereau, J., & Jospin, M. (2023) · Cells · doi:10.3390/cells12172201 · Cited by 5
“A well-studied upregulation is the one observed for neuronal receptors in response to nicotine [46,47].”
BackgroundMouse brain ATPase activities after chronic nicotine infusion
Marks, M. J., Romm, E., & Collins, A. C. (1987) · Biochemical Pharmacology · doi:10.1016/0006-2952(87)90655-1 · Cited by 4
A sensitive period in gestation for nicotine acceleration of neuromuscular maturation
Rose, K. J., & Strand, F. L. (1991) · International Journal of Developmental Neuroscience · doi:10.1016/0736-5748(91)90050-v · Cited by 4
Radioligand Labelling of Nicotinic Receptors in Mammalian Brain
Clarke, P. B. S. (1986) · Springer eBooks · doi:10.1007/978-3-642-71649-2_28 · Cited by 4
The Pharmacogenetics of Nicotine Dependence and Smoking Cessation Therapies
Adams, P. W. (2014) · Journal of Pharmacogenomics & Pharmacoproteomics · doi:10.4172/2153-0645.1000138 · Cited by 3
Metadata
- Authors
- Schwartz, R. D., & Kellar, K. J.
- Affiliations
- Georgetown University (US)
- ORCID
- Kellar, Kenneth J.
- Venue
- Science
- Published
- 1983-04-08
- Volume
- 220
- Issue
- 4593
- Pages
- 214-216
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2091374932
- Cited by
- 479
- References
- 17
- Citations by year
- 2025: 1 · 2024: 7 · 2023: 6 · 2022: 8 · 2021: 3 · 2020: 14 · 2019: 2 · 2018: 5 · 2017: 5 · 2016: 11 · 2015: 12 · 2014: 13 · 2013: 17 · 2012: 19
- FWCI
- 4.76
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nicotinic Acetylcholine Receptors Study
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Smoking Behavior and Cessation
- Keywords
- nicotinic acetylcholine receptors, receptor binding sites, diisopropylfluorophosphate, nicotine, cholinesterase inhibition, cerebral cortex, receptor regulation, receptor density, receptor binding affinity, saturation analysis
- MeSH terms
- Acetylcholine, Animals, Brain, Brain Chemistry, Cerebral Cortex, Isoflurophate, Male, Nicotine, Rats, Inbred Strains, Receptors, Cholinergic, Receptors, Nicotinic, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.